photo of

Details

Role Group Leader / Honorary Fellow Manager
Research area Infection, Immunity and Global Health
Group Molecular Microbiology
Professor Suzanne Garland is the Group Leader of the Molecular Microbiology group at MCRI.
Professor Suzanne Garland is the Group Leader of the Molecular Microbiology group at MCRI.

Top Publications

  • Park, Y-A, Subasinghe, AK, Ahmad, BS, Gorelik, A, Garland, SM, Clifford, V, Chiang, C, Robinson, H, Wark, JD. Associations Between Serum Sodium Concentration and Bone Health Measures in Individuals Who Use Antiepileptic Drugs: A Pilot Study. Journal of Clinical Densitometry 23(3) : 364 -372 2020
    view publication
  • Lawton, B, Heffernan, M, Wurtak, G, Steben, M, Lhaki, P, Cram, F, Blas, M, Hibma, M, Adcock, A, Stevenson, K, et al. IPVS Policy Statement addressing the burden of HPV disease for Indigenous peoples. Tumour Virus Research 9: 100191 2020
    view publication
  • Garland, SM, Stanley, MA, Giuliano, AR, Moscicki, A-B, Kaufmann, A, Bhatla, N, Woo, YL, Committee, IP, Palefsky, J, Chan, K, et al. IPVS statement on “Temporary HPV vaccine shortage: Implications globally to achieve equity”. Tumour Virus Research 9: 100195 2020
    view publication
  • Batmunkh, T, Dalmau, MT, Munkhsaikhan, M-E, Khorolsuren, T, Namjil, N, Surenjav, U, Toh, ZQ, Licciardi, PV, Russell, FM, Garland, SM, et al. A single dose of quadrivalent human papillomavirus (HPV) vaccine is immunogenic and reduces HPV detection rates in young women in Mongolia, six years after vaccination. Vaccine 38(27) : 4316 -4324 2020
    view publication
  • Brotherton, J, Davies, C, Committee, TIP, Garland, SM, Stanley, M, Moscicki, A-B, Giuliano, AR, Brotherton, J, Kaufmann, A, Bhatla, N, et al. IPVS policy statement. Equity in cervical cancer prevention: for all and not just for some. Tumour Virus Research 9: 100192 2020
    view publication

Page 24 of 147

Related links